Citation 109976

NISHIBE,S: SARDARI,S: KODAMA,A: HORITA,K: KUDO,M: KOIKE,K: NIKAIDO,T:. (1997). CONSTITUENTS OF BARK OF FRAXINUS AMERICANA.. 51(5)

Citation Details

Title	CONSTITUENTS OF BARK OF FRAXINUS AMERICANA.
Authors	NISHIBE,S: SARDARI,S: KODAMA,A: HORITA,K: KUDO,M: KOIKE,K: NIKAIDO,T:
Year	1997
Volume	51
Issue	5

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (2)

Fraxinus americana (OLEACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VERBASCOSIDE	None
2	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERBASCOSIDE	INACTIVE
3	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERBASCOSIDE	ACTIVE
4	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	VERBASCOSIDE	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LIGSTROSIDE,10-HYDROXY:	None
6	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIGSTROSIDE,10-HYDROXY:	INACTIVE
7	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIGSTROSIDE,10-HYDROXY:	INACTIVE
8	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LIGSTROSIDE,10-HYDROXY:	INACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LIGSTROSIDE	None
10	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIGSTROSIDE	INACTIVE
11	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIGSTROSIDE	INACTIVE
12	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LIGSTROSIDE	WEAK ACTIVITY
13	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SYRINGIN	None
14	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGIN	INACTIVE
15	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGIN	INACTIVE
16	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGIN	WEAK ACTIVITY

Fraxinus japonica (OLEACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	AESCULETIN	None
2	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	WEAK ACTIVITY
3	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	WEAK ACTIVITY
4	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OF	AESCULIN	None
6	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULIN	INACTIVE
7	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULIN	INACTIVE
8	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULIN	INACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OF	FRAXETIN	None
10	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAXETIN	INACTIVE
11	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAXETIN	INACTIVE
12	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAXETIN	INACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OF	FRAXIN	None
14	CYCLIC AMP PHOSPHODIESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAXIN	ACTIVE
15	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAXIN	INACTIVE
16	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAXIN	WEAK ACTIVITY

Show SPARQL Queries (1)